SFS 2019:553 Förordning om ändring i förordningen (1992:1554) om kontroll av narkotika

SFS2019-553.pdf

Källa Regeringskansliets rättsdatabaser m.fl.

<div><style type="text/css"> <!-- p {margin: 0; padding: 0;} .ft10{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft11{font-size:28px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft12{font-size:21px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft13{font-size:11px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft14{font-size:9px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft15{font-size:13px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft16{font-size:19px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft17{font-size:19px;font-family:VGLHPC+TimesNewRomanPS;color:#000000;} .ft18{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft19{font-size:14px;font-family:JJMNDA+TimesNewRomanPSMT;color:#000000;} .ft110{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft111{font-size:14px;line-height:18px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft20{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft21{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft22{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft23{font-size:13px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft24{font-size:9px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft25{font-size:17px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft26{font-size:17px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft27{font-size:13px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft28{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft29{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft30{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft31{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft32{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft33{font-size:18px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft34{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft35{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft36{font-size:17px;line-height:21px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft40{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft41{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft42{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft43{font-size:15px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft44{font-size:17px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft45{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft46{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft50{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft51{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft52{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft53{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft54{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft60{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft61{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft62{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft63{font-size:15px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft64{font-size:17px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft65{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft66{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft70{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft71{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft72{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft73{font-size:17px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft74{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft75{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft80{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft81{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft82{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft83{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft84{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft90{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft91{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft92{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft93{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft94{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> </style> <div id="page1-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft10">1 </p> <p style="position:absolute;top:155px;left:98px;white-space:nowrap" class="ft11"><b>Svensk f�rfattningssamling </b></p> <p style="position:absolute;top:222px;left:98px;white-space:nowrap" class="ft12"><b>F�rordning </b></p> <p style="position:absolute;top:245px;left:98px;white-space:nowrap" class="ft12"><b>om �ndring i f�rordningen (1992:1554) om kontroll av </b></p> <p style="position:absolute;top:268px;left:98px;white-space:nowrap" class="ft12"><b>narkotika </b></p> <p style="position:absolute;top:307px;left:98px;white-space:nowrap" class="ft10">Utf�rdad den 4 juli 2019 </p> <p style="position:absolute;top:348px;left:98px;white-space:nowrap" class="ft110">Regeringen f�reskriver1 att bilaga 1 till f�rordningen (1992:1554) om kon-<br/>troll av narkotika2 ska ha f�ljande lydelse. </p> <p style="position:absolute;top:410px;left:115px;white-space:nowrap" class="ft10">Denna f�rordning tr�der i kraft den 6 augusti 2019. </p> <p style="position:absolute;top:451px;left:98px;white-space:nowrap" class="ft10">P� regeringens v�gnar </p> <p style="position:absolute;top:492px;left:98px;white-space:nowrap" class="ft10">ANNIKA STRANDH�LL </p> <p style="position:absolute;top:512px;left:385px;white-space:nowrap" class="ft110">Lars Hedengran <br/>(Socialdepartementet) </p> <p style="position:absolute;top:1106px;left:98px;white-space:nowrap" class="ft14">1 Se Europaparlamentets och r�dets direktiv (EU) 2015/1535 av den 9 september 2015 om ett </p> <p style="position:absolute;top:1118px;left:98px;white-space:nowrap" class="ft15">informationsf�rfarande betr�ffande tekniska f�reskrifter och betr�ffande f�reskrifter f�r informa-</p> <p style="position:absolute;top:1130px;left:98px;white-space:nowrap" class="ft15">tionssamh�llets tj�nster. </p> <p style="position:absolute;top:1142px;left:98px;white-space:nowrap" class="ft14">2 F�rordningen omtryckt 1993:784. </p> <p style="position:absolute;top:224px;left:649px;white-space:nowrap" class="ft16"><b>SFS </b></p> <p style="position:absolute;top:221px;left:688px;white-space:nowrap" class="ft17"><b>2019:553</b></p> <p style="position:absolute;top:247px;left:649px;white-space:nowrap" class="ft111">Publicerad <br/>den </p> <p style="position:absolute;top:263px;left:674px;white-space:nowrap" class="ft19">9 juli 2019</p> </div> <div id="page2-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft20"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft20"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft21">2 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft22"><b>SFS </b></p> <p style="position:absolute;top:51px;left:568px;white-space:nowrap" class="ft23"><i>Bilaga 1</i>3<i> </i></p> <p style="position:absolute;top:86px;left:98px;white-space:nowrap" class="ft25"><b>F�rteckning �ver substanser som ska anses som narkotika enligt </b></p> <p style="position:absolute;top:105px;left:98px;white-space:nowrap" class="ft25"><b>narkotikastrafflagen </b></p> <p style="position:absolute;top:142px;left:98px;white-space:nowrap" class="ft26"><i>Centralstimulerande medel </i></p> <p style="position:absolute;top:171px;left:115px;white-space:nowrap" class="ft29">etylamfetamin (2-etylamino-1-fenylpropan) <br/>fenetyllin <br/>[1-fenyl-1-piperidyl-(2)-metyl]acetat <br/>1-fenyl-2-butylamin <br/>N-hydroxiamfetamin <br/>propylhexedrin <br/>4-metyltioamfetamin (4-MTA) <br/>modafinil <br/>4-metoxi-N-metylamfetamin (PMMA, 4-MMA) <br/>2,5-dimetoxi-4-etyltiofenetylamin (2C-T-2) <br/>2,5-dimetoxi-4-(n)-propyltiofenetylamin (2C-T-7) <br/>4-jodo-2,5-dimetoxifenetylamin (2C-I) <br/>2,4,5-trimetoxiamfetamin (TMA-2) <br/>4-metylmetkatinon (mefedron) <br/>4-fluoramfetamin <br/>1-(4-metoxifenyl)-2-(metylamino)propan-1-on (metedron) <br/>1-(1,3-bensodioxol-5-yl)-2-pyrrolidin-1-yl-pentan-1-on (MDPV) <br/>1-(1,3-bensodioxol-5-yl)-2-(metylamino)butan-1-on (butylon) <br/>1-bensylpiperazin (N-bensylpiperazin) <br/>2-metylamino-1-(3,4-metylendioxifenyl)propan-1-on (metylon) <br/>1-(naftalen-2-yl)-2-pyrrolidin-1-yl-pentan-1-on (nafyron) <br/>2-etylamin-1-fenyl-propan-1-on (N-etylkatinon) <br/>1-(2-fluorfenyl)-2-(metylamino)propan-1-on <br/>1-(3-fluorfenyl)-2-(metylamino)propan-1-on <br/>1-(4-fluorfenyl)-2-(metylamino)propan-1-on (flefedron) <br/>2-benshydrylpiperidin (desoxipipradol) <br/>metyl(E)-2-[(2S,3S,12bS)-3-etyl-8-metoxi-1,2,3,4,6,7,12,12b-okta-</p> <p style="position:absolute;top:722px;left:98px;white-space:nowrap" class="ft21">hydroindol[2,3-a]quinolizin-2-yl]-3-metoxiprop-2-enoat (mitragynin) </p> <p style="position:absolute;top:743px;left:115px;white-space:nowrap" class="ft29">(8-metyl-8-azabicyklo[3.2.1]oktan-3-yl)-4-flourbensoat (pFBT) <br/>2-etylamin-1-(4-metylfenyl)-1-propanon (4-MEC) <br/>2-metylamin-1-fenylbutan-1-on (bufedron) <br/>etyl-2-fenyl-2-(piperidin-2-yl)acetat (etylfenidat) <br/>1-(4-metylfenyl)propan-2-amin (4-MA) <br/>1-fenyl-2-(1-pyrrolidinyl)-1-propanon (�-PPP) <br/>1-fenyl-2-(pyrrolidin-1-yl)-pentan-1-on (�-PVP) <br/>1-fenyl-2-(metylamino)-pentan-1-on (pentedron) <br/>(2S)-2,6-diamino-N-[(2S)-1-fenylpropan-2-yl]hexanamid (lisdexam-</p> <p style="position:absolute;top:927px;left:98px;white-space:nowrap" class="ft21">fetamin) </p> <p style="position:absolute;top:947px;left:115px;white-space:nowrap" class="ft21">1-(2-fluorofenyl)-N-metylpropan-2-amin (2-fluorometamfetamin, </p> <p style="position:absolute;top:967px;left:98px;white-space:nowrap" class="ft21">2-FMA) </p> <p style="position:absolute;top:988px;left:115px;white-space:nowrap" class="ft21">1-(3-fluorofenyl)-N-metylpropan-2-amin (3-fluorometamfetamin, </p> <p style="position:absolute;top:1008px;left:98px;white-space:nowrap" class="ft21">3-FMA) </p> <p style="position:absolute;top:1029px;left:115px;white-space:nowrap" class="ft21">1-(4-fluorofenyl)-N-metylpropan-2-amin (4-fluorometamfetamin, </p> <p style="position:absolute;top:1049px;left:98px;white-space:nowrap" class="ft21">4-FMA) </p> <p style="position:absolute;top:1069px;left:115px;white-space:nowrap" class="ft29">1-(2-fluorofenyl)propan-2-amin (2-fluoroamfetamin) <br/>1-(3-fluorofenyl)propan-2-amin (3-fluoroamfetamin) </p> <p style="position:absolute;top:1128px;left:98px;white-space:nowrap" class="ft20"> </p> <p style="position:absolute;top:1142px;left:98px;white-space:nowrap" class="ft24">3 Senaste lydelse 2019:331. </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft28"><b>2019:553</b></p> </div> <div id="page3-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft30"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft30"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft31">3 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft32"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft31">1-(3-metylfenyl)-2-(metylamino)propan-1-on (3-MMC, 3-metylmet-</p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft31">katinon) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft35">1-(4-etylfenyl)-2-(metylamino)propan-1-on (4-EMC) <br/>6,7-dihydro-5H-cyklopenta[f][1,3]bensodioxol-6-amin (MDAI) <br/>1-(3,4-dimetylfenyl)-2-(metylamino)propan-1-on (3,4-DMMC) <br/>5-(N-etyl-2-aminopropyl)bensofuran (5-EAPB) <br/>N-metyl-1-(tiofen-2-yl)propan-2-amin (metiopropamin) <br/>5-(2-aminopropyl)indol (5-IT) <br/>1-(1,3-bensodioxol-5-yl)-2-(metylamino)pentan-1-on (pentylon) <br/>1-fenyl -2-(pyrrolidin-1-yl)butan-1-on (alfa-PBP) <br/>1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4F-alfa-PVP) <br/>1-(4-metylfenyl)-2-(pyrrolidin-1-yl)propan-1-on ( p-MePPP) <br/>metyl-2-(3,4-diklorofenyl)-2-(piperidin-2-yl)acetat (3,4-diklorometyl-</p> <p style="position:absolute;top:317px;left:98px;white-space:nowrap" class="ft31">fenidat) </p> <p style="position:absolute;top:337px;left:115px;white-space:nowrap" class="ft35">2-amino-4-metyl-5-(4-metylfenyl)-2-oxazolin (4,4-dimetylaminorex) <br/>1-(1,3-bensodioxol-5-yl)-2-(etylamino)propan-1-on (etylon) <br/>2-(etylamino)-1-fenylbutan-1-on (N-etylbufedron) <br/>1-(3-metoxifenyl)-2-(metylamino)propan-1-on (3-metoximetkatinon) <br/>1-(2-metylfenyl)-2-(metylamino)propan-1-on (2-MMC, 2-metylmet-</p> <p style="position:absolute;top:439px;left:98px;white-space:nowrap" class="ft31">katinon) </p> <p style="position:absolute;top:460px;left:115px;white-space:nowrap" class="ft35">1-(1,3-bensodioxol-5-yl)-2-(dimetylamino)butan-1-on (dibutylon) <br/>2-(etylamino)-1-(3-metylfenyl)propan-1-on (3-MEC) <br/>1-(1,3-bensodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on (MDPHP) <br/>1-(1,3-bensodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-on (MDPPP) <br/>2-(3-fluorofenyl)-3-metylmorfolin (3-fluorofenmetrazin, 3-FPM) <br/>isopropyl-2-fenyl-2-(piperidin-2-yl)acetat (isopropylfenidat) <br/>metyl-naftalen-2-yl(piperidin-2-yl)acetat (metylnaftidat, HDMP-28) <br/>propyl-2-fenyl-2-(piperidin-2-yl)acetat (propylfenidat) <br/>metyl-2-(4-fluorofenyl)-2-(piperidin-2-yl)acetat (4-fluorometylfenidat, </p> <p style="position:absolute;top:643px;left:98px;white-space:nowrap" class="ft31">4F-MPH) </p> <p style="position:absolute;top:664px;left:115px;white-space:nowrap" class="ft35">metyl-2-(4-metylfenyl)-2-(piperidin-2-yl)acetat (4-metylmetylfenidat) <br/>2-(difenylmetyl)pyrrolidin (desoxi-D2PM) <br/>metyl-3-(3,4-diklorofenyl)-8-metyl-8-azabicyklo[3.2.1]oktan-2-</p> <p style="position:absolute;top:725px;left:98px;white-space:nowrap" class="ft31">karboxylat (RTI-111, dikloropan) </p> <p style="position:absolute;top:745px;left:115px;white-space:nowrap" class="ft35">N-etyl-1-(3-fluorofenyl)propan-2-amin (3-fluoroetamfetamin, 3-FEA) <br/>1-(3-bromofenyl)-2-(metylamino)propan-1-on (3-bromometkatinon, </p> <p style="position:absolute;top:786px;left:98px;white-space:nowrap" class="ft31">3-BMC) </p> <p style="position:absolute;top:807px;left:115px;white-space:nowrap" class="ft35">2-(etylamino)-1-(3-klorofenyl)propan-1-on (3-kloroetkatinon, 3-CEC) <br/>2,5-dimetoxifenetylamin (2C-H) <br/>1-(2-metylfenyl)propan-2-amin (2-metylamfetamin, 2-MA) <br/>6-(2-aminopropyl)bensofuran (6-APB) <br/>1-fenyl-2-(pyrrolidin-1-yl)heptan-1-on (alfa-PEP) <br/>1-fenyl-2-(pyrrolidin-1-yl)hexan-1-on (alfa-PHP) <br/>1-(1,3-bensodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-on (MDPBP) <br/>1-(3-klorofenyl)-2-(metylamino)propan-1-on (3-klorometkatinon, </p> <p style="position:absolute;top:970px;left:98px;white-space:nowrap" class="ft31">3-CMC) </p> <p style="position:absolute;top:990px;left:115px;white-space:nowrap" class="ft31">1-(4-klorofenyl)-2-(metylamino)propan-1-on (4-klorometkatinon, </p> <p style="position:absolute;top:1011px;left:98px;white-space:nowrap" class="ft31">4-CMC) </p> <p style="position:absolute;top:1031px;left:115px;white-space:nowrap" class="ft36">2-amino-1-(4-bromo-2,5-dimetoxifenyl)etanon (bk-2C-B) <br/>1-(1,3-bensodioxol-5-yl)-2-(dimetylamino)propan-1-on (dimetylon) <br/>1-(1,3-bensodioxol-5-yl)-2-(dimetylamino)pentan-1-on (dipentylon) <br/>2,3-dihydro-1H-inden-2-amin (2-aminoindan</p> <p style="position:absolute;top:1093px;left:427px;white-space:nowrap" class="ft33">) </p> <p style="position:absolute;top:1115px;left:115px;white-space:nowrap" class="ft31">4-metyl-1-(4-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4-metyl-alfa-</p> <p style="position:absolute;top:1135px;left:98px;white-space:nowrap" class="ft31">PiHP) </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft34"><b>2019:553</b></p> </div> <div id="page4-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft40"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft40"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft41">4 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft42"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft41">1-(1,3-bensodioxol-5-yl)-2-(bensylamino)propan-1-on (BMDP) </p> <p style="position:absolute;top:90px;left:98px;white-space:nowrap" class="ft44"><i>Hallucinogener </i></p> <p style="position:absolute;top:118px;left:115px;white-space:nowrap" class="ft46">2-amino-1-(4-brom-2,5-dimetoxifenyl)propan (brom-STP) <br/>hydroxi-3-pentyl-6,6,9-trimetyl-6a,7,10,10a-tetrahydro-6H-dibenso[b,d] </p> <p style="position:absolute;top:159px;left:98px;white-space:nowrap" class="ft41">pyranol-(1) (hydroxitetrahydrocannabinoler) </p> <p style="position:absolute;top:180px;left:115px;white-space:nowrap" class="ft46">ibogain <br/>levonantradol <br/>nabilon <br/>4-jod-2,5-dimetoxiamfetamin (DOI) <br/>4-klor-2,5-dimetoxiamfetamin (DOC) <br/>brombensodifuranylisopropylamin (Bromo-Dragonfly) <br/>dextrometorfan med undantag f�r beredningar f�r medicinskt eller veten-</p> <p style="position:absolute;top:322px;left:98px;white-space:nowrap" class="ft41">skapligt bruk i form av l�sningar som inte inneh�ller mer �n 3 mg/ml </p> <p style="position:absolute;top:343px;left:115px;white-space:nowrap" class="ft41">5-(1,1-Dimethylhexyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol </p> <p style="position:absolute;top:363px;left:98px;white-space:nowrap" class="ft41">(CP47,497-C6) </p> <p style="position:absolute;top:384px;left:115px;white-space:nowrap" class="ft41">5-(1,1-Dimethylheptyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol </p> <p style="position:absolute;top:404px;left:98px;white-space:nowrap" class="ft41">(CP47,497-C7) </p> <p style="position:absolute;top:425px;left:115px;white-space:nowrap" class="ft41">5-(1,1-Dimethyloctyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol </p> <p style="position:absolute;top:445px;left:98px;white-space:nowrap" class="ft41">(CP47,497-C8) </p> <p style="position:absolute;top:465px;left:115px;white-space:nowrap" class="ft41">5-(1,1-Dimethylnonyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol </p> <p style="position:absolute;top:486px;left:98px;white-space:nowrap" class="ft41">(CP47,497-C9) </p> <p style="position:absolute;top:506px;left:115px;white-space:nowrap" class="ft46">Naphthalene-1-yl-(1-pentylindol-3-yl)methanon (JWH-018) <br/>Naphthalene-1-yl-(1-butylindol-3-yl)methanon (JWH-073) <br/>4-metoxinaftalen-1-yl-(1-pentylindol-3-yl)metanon (JWH-081) <br/>4-metylnaftalen-1-yl-(1-pentylindol-3-yl)metanon (JWH-122) <br/>[1-[2-(4-morfolinyl)etyl]-1H-indol-3-yl]-1-naftalenylmetanon (JWH-</p> <p style="position:absolute;top:608px;left:98px;white-space:nowrap" class="ft41">200) </p> <p style="position:absolute;top:629px;left:115px;white-space:nowrap" class="ft46">2-(2-klorophenyl)-1-(1-pentylindol-3-yl)etanon (JWH-203) <br/>4-etylnaftalen-1-yl-(1-pentylindol-3-yl)metanon (JWH-210) <br/>2-(2-metoxifenyl)-1-(1-pentyl-1H-indol-3-yl)etanon (JWH-250) <br/>(4-klornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon (JWH-398) <br/>(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) </p> <p style="position:absolute;top:731px;left:98px;white-space:nowrap" class="ft41">6a,7,10,10a,tetrahydrobenzo[c]chromen-1-ol) (HU-210) </p> <p style="position:absolute;top:751px;left:115px;white-space:nowrap" class="ft46">(2-metoxifenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4 orto isomer) <br/>2-(etylamino)-2-(3-metoxifenyl)cyklohexanon (metoxetamin) <br/>1-[(5-fluoropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (AM-2201) <br/>1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-jodofenyl)metanon (AM-694) <br/>N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin </p> <p style="position:absolute;top:853px;left:98px;white-space:nowrap" class="ft41">(5-MeO-DALT) </p> <p style="position:absolute;top:874px;left:115px;white-space:nowrap" class="ft46">3-[2-[etyl(metyl)amino]etyl]-1H-indol-4-ol (4-HO-MET) <br/>(1-(5-fluoropentyl)-1H-indol-3-yl)(4-metyl-1-naftalen-1-yl)metanon </p> <p style="position:absolute;top:915px;left:98px;white-space:nowrap" class="ft41">(MAM-2201) </p> <p style="position:absolute;top:935px;left:115px;white-space:nowrap" class="ft41">(1-((1-metylpiperidin-2-yl)metyl)-1H-indol-3-yl)(naftalen-1-yl)-</p> <p style="position:absolute;top:955px;left:98px;white-space:nowrap" class="ft41">metanon (AM-1220) </p> <p style="position:absolute;top:976px;left:115px;white-space:nowrap" class="ft41">(2-jodofenyl)(1-((1-metylpiperidin-2-yl)metyl)-1H-indol-3-yl)metanon </p> <p style="position:absolute;top:996px;left:98px;white-space:nowrap" class="ft41">(AM-2233) </p> <p style="position:absolute;top:1017px;left:115px;white-space:nowrap" class="ft41">2-(4-jodo-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin </p> <p style="position:absolute;top:1037px;left:98px;white-space:nowrap" class="ft41">(25I-NBOMe) </p> <p style="position:absolute;top:1058px;left:115px;white-space:nowrap" class="ft41">2-(4-kloro-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin </p> <p style="position:absolute;top:1078px;left:98px;white-space:nowrap" class="ft41">(25C-NBOMe) </p> <p style="position:absolute;top:1098px;left:115px;white-space:nowrap" class="ft41">2-(4-bromo-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin </p> <p style="position:absolute;top:1119px;left:98px;white-space:nowrap" class="ft41">(25B-NBOMe) </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft45"><b>2019:553</b></p> </div> <div id="page5-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft50"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft50"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft51">5 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft52"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft51">2-(2,5-dimetoxi-4-metylfenyl)-N-(2-metoxibensyl)etanamin </p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft51">(25D-NBOMe) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft54">2-(2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin (25H-NBOMe) <br/>(1-(5-fluoropentyl)-1H-indol-3-yl)(4-etyl-naftalen-1-yl)metanon </p> <p style="position:absolute;top:133px;left:98px;white-space:nowrap" class="ft51">(EAM-2201) </p> <p style="position:absolute;top:153px;left:115px;white-space:nowrap" class="ft51">2-(4-jodo-2,5-dimetoxifenyl)-N-[(2,3-metylendioxifenyl)metyl]eta-</p> <p style="position:absolute;top:174px;left:98px;white-space:nowrap" class="ft51">namin (25I-NBMD) </p> <p style="position:absolute;top:194px;left:115px;white-space:nowrap" class="ft51">2-(2,5-dimetoxi-3,4-dimetylfenyl)-N-(2-metoxibensyl)etanamin </p> <p style="position:absolute;top:215px;left:98px;white-space:nowrap" class="ft51">(25G-NBOMe) </p> <p style="position:absolute;top:235px;left:115px;white-space:nowrap" class="ft51">2-(2,5-dimetoxi-4-nitrofenyl)-N-(2-metoxibensyl)etanamin </p> <p style="position:absolute;top:255px;left:98px;white-space:nowrap" class="ft51">(25N-NBOMe) </p> <p style="position:absolute;top:276px;left:115px;white-space:nowrap" class="ft51">2-(4-jodo-2,5-dimetoxifenyl)-N-[(3,4-metylendioxifenyl)metyl]eta-</p> <p style="position:absolute;top:296px;left:98px;white-space:nowrap" class="ft51">namin (25I-NB34MD) </p> <p style="position:absolute;top:317px;left:115px;white-space:nowrap" class="ft51">2-(4-kloro-2,5-dimetoxifenyl)-N-(3,4,5-trimetoxibensyl)etanamin </p> <p style="position:absolute;top:337px;left:98px;white-space:nowrap" class="ft51">(C30-NBOMe) </p> <p style="position:absolute;top:358px;left:115px;white-space:nowrap" class="ft51">N-[2-(5-metoxi-1H-indol-3-yl)etyl]-N-metylpropan-2-amin </p> <p style="position:absolute;top:378px;left:98px;white-space:nowrap" class="ft51">(5-MeO-MIPT) </p> <p style="position:absolute;top:398px;left:115px;white-space:nowrap" class="ft54">2-([2-(4-jodo-2,5-dimetoxifenyl)etylamino]metyl)fenol (25I-NBOH) <br/>3-[2-(dipropylamino)etyl]indol (N,N-dipropyltryptamin, DPT) <br/>6-allyl-N,N-dietyl-9,10-didehydroergolin-8-karboxamid (6-allyl-6-nor-</p> <p style="position:absolute;top:460px;left:98px;white-space:nowrap" class="ft51">LSD, AL-LAD) </p> <p style="position:absolute;top:480px;left:115px;white-space:nowrap" class="ft51">(2,4-dimetylazetidin-1-yl)(6-metyl-9,10-didehydroergolin-8-yl)metanon </p> <p style="position:absolute;top:500px;left:98px;white-space:nowrap" class="ft51">(LSZ) </p> <p style="position:absolute;top:521px;left:115px;white-space:nowrap" class="ft54">4-allyloxi-3,5-dimetoxifenetylamin (allyleskalin) <br/>4-(2-metyl)allyloxi-3,5-dimetoxifenetylamin (metallyleskalin) <br/>4-etoxi-3,5-dimetoxifenetylamin (eskalin) <br/>2-([2-(4-bromo-2,5-dimetoxifenyl)etylamino]metyl)fenol (25B-NBOH) <br/>2-(4-bromo-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin (25B-NBF) <br/>2-(4-kloro-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin (25C-NBF) <br/>2-(4-jodo-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin (25I-NBF) <br/>2,5-dimetoxi-4-propylfenetylamin (2C-P) <br/>4-acetoxi-N,N-dimetyltryptamin (4-AcO-DMT) <br/>3,5-dimetoxi-4-propoxifenetylamin (proskalin) <br/>1-acetyl-N,N-dietyl-6-metyl-9,10-didehydroergolin-8-karboxamid </p> <p style="position:absolute;top:745px;left:98px;white-space:nowrap" class="ft51">(ALD-52) </p> <p style="position:absolute;top:766px;left:115px;white-space:nowrap" class="ft54">N,N,6-trietyl-9,10-didehydroergolin-8-karboxamid (ETH-LAD) <br/>2-(8-bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]bensofuran-4-yl)etanamin </p> <p style="position:absolute;top:807px;left:98px;white-space:nowrap" class="ft51">(2C-B-FLY) </p> <p style="position:absolute;top:827px;left:115px;white-space:nowrap" class="ft51">metyl-2-[1-(5-fluoropentyl)-1H-indol-3-karboxamido]-3,3-dimetyl-</p> <p style="position:absolute;top:847px;left:98px;white-space:nowrap" class="ft51">butanoat (5F-MDMB-PICA) </p> <p style="position:absolute;top:868px;left:115px;white-space:nowrap" class="ft51">metyl-2-[1-(4-fluorobensyl)-1H-indol-3-karboxamido]-3-metylbutanoat </p> <p style="position:absolute;top:888px;left:98px;white-space:nowrap" class="ft51">(MMB-FUBICA, AMB-FUBICA) </p> <p style="position:absolute;top:909px;left:115px;white-space:nowrap" class="ft51">3-[1-(piperidin-1-yl)cyklohexyl]fenol (3-hydroxifencyklidin, </p> <p style="position:absolute;top:929px;left:98px;white-space:nowrap" class="ft51">3-HO-PCP) </p> <p style="position:absolute;top:950px;left:115px;white-space:nowrap" class="ft51">N-etyl-1-(3-metoxifenyl)cyklohexan-1-amin (3-metoxieticyklidin, </p> <p style="position:absolute;top:970px;left:98px;white-space:nowrap" class="ft51">3-MeO-PCE) </p> <p style="position:absolute;top:990px;left:115px;white-space:nowrap" class="ft51">2-(etylamino)-2-fenylcyklohexan-1-on (deskloro-N-etylnorketamin, </p> <p style="position:absolute;top:1011px;left:98px;white-space:nowrap" class="ft51">O-PCE) </p> <p style="position:absolute;top:1031px;left:115px;white-space:nowrap" class="ft54">2-[([2-(4-etyl-2,5-dimetoxifenyl)etyl]amino)metyl]fenol (25E-NBOH) <br/>2-(4-etyl-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin (25E-</p> <p style="position:absolute;top:1072px;left:98px;white-space:nowrap" class="ft51">NBOMe) </p> <p style="position:absolute;top:1092px;left:115px;white-space:nowrap" class="ft51">metyl-2-([1-(cyklohexylmetyl)-1H-indazol-3-karbonyl]amino)-3-metyl-</p> <p style="position:absolute;top:1113px;left:98px;white-space:nowrap" class="ft51">butanoat (AMB-CHMINACA) </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft53"><b>2019:553</b></p> </div> <div id="page6-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft60"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft60"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft61">6 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft62"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft61">2-(2-fenylpropan-2-yl)-5-pentyl-2,5-dihydro-1H-pyrido[4,3-b]indol-1-</p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft61">on (CUMYL-PeGACLONE) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft61">N-[1-(2,3-dihydro-1,4-bensodioxin-6-yl)propan-2-yl]-N-metylhydroxyl-</p> <p style="position:absolute;top:113px;left:98px;white-space:nowrap" class="ft61">amin (EFLEA) </p> <p style="position:absolute;top:133px;left:115px;white-space:nowrap" class="ft61">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-[(4-fluorofenyl)metyl]-1H-</p> <p style="position:absolute;top:153px;left:98px;white-space:nowrap" class="ft61">indazol-3-karboxamid (ADB-FUBINACA) </p> <p style="position:absolute;top:174px;left:115px;white-space:nowrap" class="ft61">[1-(4-fluorobensyl)-1H-indol-3-yl](2,2,3,3-tetrametylcyklo-</p> <p style="position:absolute;top:194px;left:98px;white-space:nowrap" class="ft61">propyl)metanon (FUB-144) </p> <p style="position:absolute;top:215px;left:115px;white-space:nowrap" class="ft66">[1-(5-fluoropentyl)-1H-indazol-3-yl](naftalen-1-yl)metanon (THJ-2201) <br/>3-(2-[di(propan-2-yl)amino]etyl)-1H-indol-4-ol (4-HO-DIPT) <br/>3-[2-(dimetylamino)etyl]-1H-indol-5-ol (5-HO-DMT) <br/>N,N-dietyl-2-(5-metoxi-1H-indol-3-yl)etanamin (5-MeO-DET) <br/>N-[2-(5-metoxi-1H-indol-3-yl)etyl]-N-metylprop-2-en-1-amin (5-MeO-</p> <p style="position:absolute;top:317px;left:98px;white-space:nowrap" class="ft61">MALT) </p> <p style="position:absolute;top:337px;left:115px;white-space:nowrap" class="ft66">N-[2-(5-metoxi-1H-indol-3-yl)etyl]propan-2-amin (5-MeO-NIPT) <br/>N-[2-(1H-indol-3-yl)etyl]-N-(propan-2-yl)propan-2-amin (DIPT) <br/>N-[2-(1H-indol-3-yl)etyl]-N-metylpropan-2-amin (MIPT) <br/>N,N-dietyl-6-metyl-1-propanoyl-9,10-didehydroergolin-8-karboxamid </p> <p style="position:absolute;top:419px;left:98px;white-space:nowrap" class="ft61">(1P-LSD) </p> <p style="position:absolute;top:457px;left:98px;white-space:nowrap" class="ft64"><i>Sm�rtstillande medel </i></p> <p style="position:absolute;top:486px;left:115px;white-space:nowrap" class="ft66">karfentanil <br/>karisoprodol <br/>remifentanil <br/>gamma-hydroxi-butyrat (GHB) <br/>ketamin <br/>tapentadol <br/>tramadol <br/>O-desmetyltramadol (ODT) <br/>3,4-dikloro-N-[[1-(dimetylamino)cyklohexyl]metyl]bensamid </p> <p style="position:absolute;top:670px;left:98px;white-space:nowrap" class="ft61">(AH-7921) </p> <p style="position:absolute;top:690px;left:115px;white-space:nowrap" class="ft66">1-cyklohexyl-4-(1,2-difenyletyl)piperazin (MT-45) <br/>4-kloro-N-(1-(2-fenyletyl)-piperidin-2-yliden)bensensulfonamid (W-15) <br/>1-[1-(3-metoxifenyl)cyklohexyl]piperidin (3-MeO-PCP) <br/>1-[1-(4-metoxifenyl)cyklohexyl]piperidin (4-MeO-PCP) <br/>2-(etylamino)-2-(2-klorofenyl)cyklohexan-1-on (N-etylnorketamin) <br/>1-(1,2-difenyletyl)piperidin (difenidin) <br/>1-[2-fenyl-1-(2-metoxifenyl)etyl]piperidin (2-MeO-difenidin) <br/>N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]acetamid (acetylfentanyl) <br/>N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]butanamid (butyrfentanyl) <br/>N-[1-(2-fenyletyl)piperidin-4-yl]-N-(2-fluorofenyl)-2-metoxiacetamid </p> <p style="position:absolute;top:894px;left:98px;white-space:nowrap" class="ft61">(ocfentanyl) </p> <p style="position:absolute;top:915px;left:115px;white-space:nowrap" class="ft61">3,4-dikloro-N-[2-(dimetylamino)cyklohexyl]-N-metylbensamid </p> <p style="position:absolute;top:935px;left:98px;white-space:nowrap" class="ft61">(U-47700) </p> <p style="position:absolute;top:955px;left:115px;white-space:nowrap" class="ft61">4-kloro-N-(1-[2-(4-nitrofenyl)etyl]piperidin-2-yliden)bensensulfonamid </p> <p style="position:absolute;top:976px;left:98px;white-space:nowrap" class="ft61">(W-18) </p> <p style="position:absolute;top:996px;left:115px;white-space:nowrap" class="ft66">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-2-propenamid (akrylfentanyl) <br/>2-(etylamino)-2-(tiofen-2-yl)cyklohexan-1-on (tiletamin) <br/>N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]furan-2-karboxamid </p> <p style="position:absolute;top:1058px;left:98px;white-space:nowrap" class="ft61">(furanylfentanyl, Fu-F) </p> <p style="position:absolute;top:1078px;left:115px;white-space:nowrap" class="ft61">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-2-metylpropanamid </p> <p style="position:absolute;top:1098px;left:98px;white-space:nowrap" class="ft61">(isobutyrfentanyl) </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft65"><b>2019:553</b></p> </div> <div id="page7-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft70"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft70"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft71">7 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft72"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft71">metyl-4-[fenyl(metoxiacetyl)amino]-1-[2-(2-tienyl)etyl]piperidin-4-</p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft71">karboxylat (tiafentanil) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft71">N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-fluorofenyl)-2-metylpropanamid </p> <p style="position:absolute;top:113px;left:98px;white-space:nowrap" class="ft71">(4-fluoroisobutyrfentanyl, 4F-iBF) </p> <p style="position:absolute;top:133px;left:115px;white-space:nowrap" class="ft71">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]cyklopropankarboxamid </p> <p style="position:absolute;top:153px;left:98px;white-space:nowrap" class="ft71">(cyklopropylfentanyl) </p> <p style="position:absolute;top:174px;left:115px;white-space:nowrap" class="ft71">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-2-metoxiacetamid </p> <p style="position:absolute;top:194px;left:98px;white-space:nowrap" class="ft71">(metoxiacetylfentanyl) </p> <p style="position:absolute;top:215px;left:115px;white-space:nowrap" class="ft71">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]tetrahydrofuran-2-karboxamid </p> <p style="position:absolute;top:235px;left:98px;white-space:nowrap" class="ft71">(tetrahydrofuranfentanyl, THF-F) </p> <p style="position:absolute;top:255px;left:115px;white-space:nowrap" class="ft75">4-bromo-N-[2-(dimetylamino)cyklohexyl]bensamid (bromadolin) <br/>N-[1-(2-fenyletyl)piperidin-4-yl]-N-(2-fluorofenyl)propanamid </p> <p style="position:absolute;top:296px;left:98px;white-space:nowrap" class="ft71">(2-fluorofentanyl) </p> <p style="position:absolute;top:317px;left:115px;white-space:nowrap" class="ft71">N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-fluorofenyl)butanamid </p> <p style="position:absolute;top:337px;left:98px;white-space:nowrap" class="ft71">(4-fluorobutyrfentanyl, 4F-BF) </p> <p style="position:absolute;top:358px;left:115px;white-space:nowrap" class="ft71">N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-metoxifenyl)butanamid </p> <p style="position:absolute;top:378px;left:98px;white-space:nowrap" class="ft71">(4-metoxibutyrfentanyl, 4-MeO-BF) </p> <p style="position:absolute;top:398px;left:115px;white-space:nowrap" class="ft71">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]cyklopentankarboxamid </p> <p style="position:absolute;top:419px;left:98px;white-space:nowrap" class="ft71">(cyklopentylfentanyl) </p> <p style="position:absolute;top:439px;left:115px;white-space:nowrap" class="ft75">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]pentanamid (valerylfentanyl) <br/>1-[4-(3-fenylprop-2-en-1-yl)-2-metylpiperazin-1-yl]butan-1-on </p> <p style="position:absolute;top:480px;left:98px;white-space:nowrap" class="ft71">(2-metyl-AP-237) </p> <p style="position:absolute;top:518px;left:98px;white-space:nowrap" class="ft73"><i>S�mnmedel och lugnande medel </i></p> <p style="position:absolute;top:547px;left:115px;white-space:nowrap" class="ft75">allobarbital <br/>aprobarbital <br/>brallobarbital <br/>brotizolam <br/>butalbarbital <br/>pyrityldion (3,3-dietyl-2,4-dioxotetrahydropyridin) <br/>heptabarbital <br/>hexapropymat <br/>hexobarbital <br/>klometiazol <br/>kloralhydrat <br/>kloralodol <br/>metohexital <br/>metylpentynol <br/>midazolam <br/>tybamat <br/>vinbarbital <br/>zolpidem <br/>zopiclone <br/>fenazepam <br/>etizolam (4-(o-klorofenyl)-2-etyl-9-metyl-6H-tieno[3,2-f]-s-tria-</p> <p style="position:absolute;top:976px;left:98px;white-space:nowrap" class="ft71">zolo[4,3-a][1,4]diazepin) </p> <p style="position:absolute;top:996px;left:115px;white-space:nowrap" class="ft71">8-bromo-1-metyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benso-</p> <p style="position:absolute;top:1017px;left:98px;white-space:nowrap" class="ft71">diazepin (pyrazolam) </p> <p style="position:absolute;top:1037px;left:115px;white-space:nowrap" class="ft71">7-bromo-5-(2-fluorofenyl)-1,3-dihydro-2H-1,4-bensodiazepin-2-on </p> <p style="position:absolute;top:1058px;left:98px;white-space:nowrap" class="ft71">(flubromazepam) </p> <p style="position:absolute;top:1078px;left:115px;white-space:nowrap" class="ft71">7-kloro-5-(2-klorofenyl)-1,3-dihydro-1-metyl-2H-1,4-bensodiazepin-</p> <p style="position:absolute;top:1098px;left:98px;white-space:nowrap" class="ft71">2-on (diklazepam) </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft74"><b>2019:553</b></p> </div> <div id="page8-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft80"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft80"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft81">8 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft82"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft81">(8-bromo-6-(2-fluorofenyl)-1-metyl-4H-[1,2,4]triazolo[4,3-a][1,4] ben-</p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft81">sodiazepin (flubromazolam) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft81">5-(2-klorofenyl)-3-metyl-7-nitro-1,3-dihydro-2H-[1,4]-bensodiazepin-</p> <p style="position:absolute;top:113px;left:98px;white-space:nowrap" class="ft81">2-on (meklonazepam) </p> <p style="position:absolute;top:133px;left:115px;white-space:nowrap" class="ft81">6-(2-klorofenyl)-1-metyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]bensodia-</p> <p style="position:absolute;top:153px;left:98px;white-space:nowrap" class="ft81">zepin (klonazolam) </p> <p style="position:absolute;top:174px;left:115px;white-space:nowrap" class="ft81">2-etyl-4-fenyl-9-metyl-6H-tieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin </p> <p style="position:absolute;top:194px;left:98px;white-space:nowrap" class="ft81">(deskloretizolam) </p> <p style="position:absolute;top:215px;left:115px;white-space:nowrap" class="ft81">2-etyl-4-(2-klorofenyl)-6H-tieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]dia-</p> <p style="position:absolute;top:235px;left:98px;white-space:nowrap" class="ft81">zepin (metizolam) </p> <p style="position:absolute;top:255px;left:115px;white-space:nowrap" class="ft81">1-(6-fenyl-8-kloro-4H-[1,2,4]triazolo[4,3-a][1,4]bensodiazepin-1-yl)-</p> <p style="position:absolute;top:276px;left:98px;white-space:nowrap" class="ft81">N,N-dimetylmetanamin (adinazolam) </p> <p style="position:absolute;top:296px;left:115px;white-space:nowrap" class="ft81">1-(cyklopropylmetyl)-5-(2-klorofenyl)-7-nitro-1,3-dihydro-2H-[1,4]-</p> <p style="position:absolute;top:317px;left:98px;white-space:nowrap" class="ft81">bensodiazepin-2-on (kloniprazepam) </p> <p style="position:absolute;top:337px;left:115px;white-space:nowrap" class="ft81">8-kloro-6-(2-klorofenyl)-4H-pyrido[2,3-f][1,2,4]triazolo[4,3-a][1,4]dia-</p> <p style="position:absolute;top:358px;left:98px;white-space:nowrap" class="ft81">zepin (zapizolam) </p> <p style="position:absolute;top:378px;left:115px;white-space:nowrap" class="ft81">5-(2-fluorofenyl)-3-hydroxi-7-nitro-1,3-dihydro-2H-1,4-bensodiazepin-</p> <p style="position:absolute;top:398px;left:98px;white-space:nowrap" class="ft81">2-on (nifoxipam, 3-hydroxidesmetylflunitrazepam) </p> <p style="position:absolute;top:419px;left:115px;white-space:nowrap" class="ft81">7-bromo-3-hydroxi-5-(2-klorofenyl)-1,3-dihydro-2H-1,4-bensodiazepin-</p> <p style="position:absolute;top:439px;left:98px;white-space:nowrap" class="ft81">2-on (3-hydroxifenazepam) </p> <p style="position:absolute;top:460px;left:115px;white-space:nowrap" class="ft81">6-(2-fluorofenyl)-1-metyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]bensodi-</p> <p style="position:absolute;top:480px;left:98px;white-space:nowrap" class="ft81">azepin (flunitrazolam) </p> <p style="position:absolute;top:500px;left:115px;white-space:nowrap" class="ft81">5-(2-fluorofenyl)-1,3-dihydro-7-nitro-2H-1,4-bensodiazepin-2-on </p> <p style="position:absolute;top:521px;left:98px;white-space:nowrap" class="ft81">(N-desmetylflunitrazepam) </p> <p style="position:absolute;top:541px;left:115px;white-space:nowrap" class="ft81">8-bromo-6-fenyl-1-metyl-4H-[1,2,4]triazolo[4,3-a][1,4]bensodiazepin </p> <p style="position:absolute;top:562px;left:98px;white-space:nowrap" class="ft81">(bromazolam) </p> <p style="position:absolute;top:582px;left:115px;white-space:nowrap" class="ft81">5-(2-fluorofenyl)-7-kloro-1,3-dihydro-2H-1,4-bensodiazepin-2-on </p> <p style="position:absolute;top:602px;left:98px;white-space:nowrap" class="ft81">(norfludiazepam) </p> <p style="position:absolute;top:623px;left:115px;white-space:nowrap" class="ft81">6-(2-fluorofenyl)-8-kloro-1-metyl-4H-[1,2,4]triazolo[4,3-a][1,4]benso-</p> <p style="position:absolute;top:643px;left:98px;white-space:nowrap" class="ft81">diazepin (flualprazolam) </p> <p style="position:absolute;top:664px;left:115px;white-space:nowrap" class="ft81">6-fenyl-1-metyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]bensodiazepin </p> <p style="position:absolute;top:684px;left:98px;white-space:nowrap" class="ft81">(nitrazolam) </p> <p style="position:absolute;top:705px;left:115px;white-space:nowrap" class="ft84">(3S)-3-(aminometyl)-5-metylhexansyra (pregabalin) <br/>5-(2-klorofenyl)-1-metyl-7-nitro-1,3-dihydro-2H-1,4-bensodiazepin-</p> <p style="position:absolute;top:745px;left:98px;white-space:nowrap" class="ft81">2-on (metylklonazepam) </p> <p style="position:absolute;top:766px;left:115px;white-space:nowrap" class="ft81">5-fenyl-1,3,6,7,8,9-hexahydro-2H-[1]bensotieno[2,3-e][1,4]diazepin-2-</p> <p style="position:absolute;top:786px;left:98px;white-space:nowrap" class="ft81">on (bentazepam) </p> <p style="position:absolute;top:807px;left:115px;white-space:nowrap" class="ft84"> <br/>Som narkotika enligt narkotikastrafflagen ska �ven anses de ovanjordiska </p> <p style="position:absolute;top:847px;left:98px;white-space:nowrap" class="ft84">delarna av v�xten kat (Catha edulis) samt svamparna Psilocybe semilanceata <br/>(toppsl�tskivling) och Psilocybe cubensis. Detsamma ska g�lla andra <br/>svampar som inneh�ller �mnena psilocybin eller psilocin, om svamparna �r <br/>framodlade eller om de har torkats eller p� annat s�tt beretts. </p> <p style="position:absolute;top:929px;left:115px;white-space:nowrap" class="ft81">Vidare ska vid till�mpning av lagen med cannabis f�rst�s de ovanjordiska </p> <p style="position:absolute;top:950px;left:98px;white-space:nowrap" class="ft84">delarna av varje v�xt av sl�ktet Cannabis (med undantag av fr�n), fr�n vilka <br/>hartset inte blivit extraherat och oavsett under vilka ben�mningar de f�re-<br/>kommer. Med cannabis ska dock inte f�rst�s hampa som </p> <p style="position:absolute;top:1011px;left:115px;white-space:nowrap" class="ft81">1. �r av en sort som kan ber�ttiga till st�d enligt r�dets f�rordning (EG) </p> <p style="position:absolute;top:1031px;left:98px;white-space:nowrap" class="ft84">nr 73/2009 av den 19 januari 2009 om uppr�ttande av gemensamma best�m-<br/>melser f�r system f�r direktst�d f�r jordbrukare inom den gemensamma <br/>jordbrukspolitiken och om uppr�ttande av vissa st�dsystem f�r jordbrukare, <br/>om �ndring av f�rordningarna (EG) nr 1290/2005, (EG) nr 247/2006 och <br/>(EG) nr 378/2007 samt om upph�vande av f�rordning (EG) nr 1782/2003, </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft83"><b>2019:553</b></p> </div> <div id="page9-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft90"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft90"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft91">9 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft92"><b>SFS </b></p> <p style="position:absolute;top:51px;left:98px;white-space:nowrap" class="ft94">Europaparlamentets och r�dets f�rordning (EU) nr 1307/2013 av den 17 de-<br/>cember 2013 om regler f�r direktst�d f�r jordbrukare inom de st�dordningar <br/>som ing�r i den gemensamma jordbrukspolitiken och om upph�vande av <br/>r�dets f�rordning (EG) nr 637/2008 och r�dets f�rordning (EG) 73/2009, <br/>och Europaparlamentets och r�dets f�rordning (EU) nr 1308/2013 av den <br/>17 december 2013 om uppr�ttande av en samlad marknadsordning f�r jord-<br/>bruksprodukter och om upph�vande av r�dets f�rordningar (EEG) <br/>nr 922/72, (EEG) nr 234/79, (EG) nr 1037/2001 och (EG) nr 1234/2007, och </p> <p style="position:absolute;top:215px;left:115px;white-space:nowrap" class="ft91">2. odlas efter det att ans�kan om direktst�d f�r s�dan odling enligt r�dets </p> <p style="position:absolute;top:235px;left:98px;white-space:nowrap" class="ft94">f�rordning (EG) nr 1307/2013 eller r�dets f�rordning (EG) nr 73/2009 getts <br/>in till beh�rig myndighet. <br/> </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft93"><b>2019:553</b></p> </div> </div>
background image

1

Svensk f�rfattningssamling

F�rordning

om �ndring i f�rordningen (1992:1554) om kontroll av

narkotika

Utf�rdad den 4 juli 2019

Regeringen f�reskriver1 att bilaga 1 till f�rordningen (1992:1554) om kon-
troll av narkotika2 ska ha f�ljande lydelse.

Denna f�rordning tr�der i kraft den 6 augusti 2019.

P� regeringens v�gnar

ANNIKA STRANDH�LL

Lars Hedengran
(Socialdepartementet)

1 Se Europaparlamentets och r�dets direktiv (EU) 2015/1535 av den 9 september 2015 om ett

informationsf�rfarande betr�ffande tekniska f�reskrifter och betr�ffande f�reskrifter f�r informa-

tionssamh�llets tj�nster.

2 F�rordningen omtryckt 1993:784.

SFS

2019:553

Publicerad
den

9 juli 2019

background image

2

SFS

Bilaga 13

F�rteckning �ver substanser som ska anses som narkotika enligt

narkotikastrafflagen

Centralstimulerande medel

etylamfetamin (2-etylamino-1-fenylpropan)
fenetyllin
[1-fenyl-1-piperidyl-(2)-metyl]acetat
1-fenyl-2-butylamin
N-hydroxiamfetamin
propylhexedrin
4-metyltioamfetamin (4-MTA)
modafinil
4-metoxi-N-metylamfetamin (PMMA, 4-MMA)
2,5-dimetoxi-4-etyltiofenetylamin (2C-T-2)
2,5-dimetoxi-4-(n)-propyltiofenetylamin (2C-T-7)
4-jodo-2,5-dimetoxifenetylamin (2C-I)
2,4,5-trimetoxiamfetamin (TMA-2)
4-metylmetkatinon (mefedron)
4-fluoramfetamin
1-(4-metoxifenyl)-2-(metylamino)propan-1-on (metedron)
1-(1,3-bensodioxol-5-yl)-2-pyrrolidin-1-yl-pentan-1-on (MDPV)
1-(1,3-bensodioxol-5-yl)-2-(metylamino)butan-1-on (butylon)
1-bensylpiperazin (N-bensylpiperazin)
2-metylamino-1-(3,4-metylendioxifenyl)propan-1-on (metylon)
1-(naftalen-2-yl)-2-pyrrolidin-1-yl-pentan-1-on (nafyron)
2-etylamin-1-fenyl-propan-1-on (N-etylkatinon)
1-(2-fluorfenyl)-2-(metylamino)propan-1-on
1-(3-fluorfenyl)-2-(metylamino)propan-1-on
1-(4-fluorfenyl)-2-(metylamino)propan-1-on (flefedron)
2-benshydrylpiperidin (desoxipipradol)
metyl(E)-2-[(2S,3S,12bS)-3-etyl-8-metoxi-1,2,3,4,6,7,12,12b-okta-

hydroindol[2,3-a]quinolizin-2-yl]-3-metoxiprop-2-enoat (mitragynin)

(8-metyl-8-azabicyklo[3.2.1]oktan-3-yl)-4-flourbensoat (pFBT)
2-etylamin-1-(4-metylfenyl)-1-propanon (4-MEC)
2-metylamin-1-fenylbutan-1-on (bufedron)
etyl-2-fenyl-2-(piperidin-2-yl)acetat (etylfenidat)
1-(4-metylfenyl)propan-2-amin (4-MA)
1-fenyl-2-(1-pyrrolidinyl)-1-propanon (�-PPP)
1-fenyl-2-(pyrrolidin-1-yl)-pentan-1-on (�-PVP)
1-fenyl-2-(metylamino)-pentan-1-on (pentedron)
(2S)-2,6-diamino-N-[(2S)-1-fenylpropan-2-yl]hexanamid (lisdexam-

fetamin)

1-(2-fluorofenyl)-N-metylpropan-2-amin (2-fluorometamfetamin,

2-FMA)

1-(3-fluorofenyl)-N-metylpropan-2-amin (3-fluorometamfetamin,

3-FMA)

1-(4-fluorofenyl)-N-metylpropan-2-amin (4-fluorometamfetamin,

4-FMA)

1-(2-fluorofenyl)propan-2-amin (2-fluoroamfetamin)
1-(3-fluorofenyl)propan-2-amin (3-fluoroamfetamin)

3 Senaste lydelse 2019:331.

2019:553

background image

3

SFS

1-(3-metylfenyl)-2-(metylamino)propan-1-on (3-MMC, 3-metylmet-

katinon)

1-(4-etylfenyl)-2-(metylamino)propan-1-on (4-EMC)
6,7-dihydro-5H-cyklopenta[f][1,3]bensodioxol-6-amin (MDAI)
1-(3,4-dimetylfenyl)-2-(metylamino)propan-1-on (3,4-DMMC)
5-(N-etyl-2-aminopropyl)bensofuran (5-EAPB)
N-metyl-1-(tiofen-2-yl)propan-2-amin (metiopropamin)
5-(2-aminopropyl)indol (5-IT)
1-(1,3-bensodioxol-5-yl)-2-(metylamino)pentan-1-on (pentylon)
1-fenyl -2-(pyrrolidin-1-yl)butan-1-on (alfa-PBP)
1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4F-alfa-PVP)
1-(4-metylfenyl)-2-(pyrrolidin-1-yl)propan-1-on ( p-MePPP)
metyl-2-(3,4-diklorofenyl)-2-(piperidin-2-yl)acetat (3,4-diklorometyl-

fenidat)

2-amino-4-metyl-5-(4-metylfenyl)-2-oxazolin (4,4-dimetylaminorex)
1-(1,3-bensodioxol-5-yl)-2-(etylamino)propan-1-on (etylon)
2-(etylamino)-1-fenylbutan-1-on (N-etylbufedron)
1-(3-metoxifenyl)-2-(metylamino)propan-1-on (3-metoximetkatinon)
1-(2-metylfenyl)-2-(metylamino)propan-1-on (2-MMC, 2-metylmet-

katinon)

1-(1,3-bensodioxol-5-yl)-2-(dimetylamino)butan-1-on (dibutylon)
2-(etylamino)-1-(3-metylfenyl)propan-1-on (3-MEC)
1-(1,3-bensodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on (MDPHP)
1-(1,3-bensodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-on (MDPPP)
2-(3-fluorofenyl)-3-metylmorfolin (3-fluorofenmetrazin, 3-FPM)
isopropyl-2-fenyl-2-(piperidin-2-yl)acetat (isopropylfenidat)
metyl-naftalen-2-yl(piperidin-2-yl)acetat (metylnaftidat, HDMP-28)
propyl-2-fenyl-2-(piperidin-2-yl)acetat (propylfenidat)
metyl-2-(4-fluorofenyl)-2-(piperidin-2-yl)acetat (4-fluorometylfenidat,

4F-MPH)

metyl-2-(4-metylfenyl)-2-(piperidin-2-yl)acetat (4-metylmetylfenidat)
2-(difenylmetyl)pyrrolidin (desoxi-D2PM)
metyl-3-(3,4-diklorofenyl)-8-metyl-8-azabicyklo[3.2.1]oktan-2-

karboxylat (RTI-111, dikloropan)

N-etyl-1-(3-fluorofenyl)propan-2-amin (3-fluoroetamfetamin, 3-FEA)
1-(3-bromofenyl)-2-(metylamino)propan-1-on (3-bromometkatinon,

3-BMC)

2-(etylamino)-1-(3-klorofenyl)propan-1-on (3-kloroetkatinon, 3-CEC)
2,5-dimetoxifenetylamin (2C-H)
1-(2-metylfenyl)propan-2-amin (2-metylamfetamin, 2-MA)
6-(2-aminopropyl)bensofuran (6-APB)
1-fenyl-2-(pyrrolidin-1-yl)heptan-1-on (alfa-PEP)
1-fenyl-2-(pyrrolidin-1-yl)hexan-1-on (alfa-PHP)
1-(1,3-bensodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-on (MDPBP)
1-(3-klorofenyl)-2-(metylamino)propan-1-on (3-klorometkatinon,

3-CMC)

1-(4-klorofenyl)-2-(metylamino)propan-1-on (4-klorometkatinon,

4-CMC)

2-amino-1-(4-bromo-2,5-dimetoxifenyl)etanon (bk-2C-B)
1-(1,3-bensodioxol-5-yl)-2-(dimetylamino)propan-1-on (dimetylon)
1-(1,3-bensodioxol-5-yl)-2-(dimetylamino)pentan-1-on (dipentylon)
2,3-dihydro-1H-inden-2-amin (2-aminoindan

)

4-metyl-1-(4-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4-metyl-alfa-

PiHP)

2019:553

background image

4

SFS

1-(1,3-bensodioxol-5-yl)-2-(bensylamino)propan-1-on (BMDP)

Hallucinogener

2-amino-1-(4-brom-2,5-dimetoxifenyl)propan (brom-STP)
hydroxi-3-pentyl-6,6,9-trimetyl-6a,7,10,10a-tetrahydro-6H-dibenso[b,d]

pyranol-(1) (hydroxitetrahydrocannabinoler)

ibogain
levonantradol
nabilon
4-jod-2,5-dimetoxiamfetamin (DOI)
4-klor-2,5-dimetoxiamfetamin (DOC)
brombensodifuranylisopropylamin (Bromo-Dragonfly)
dextrometorfan med undantag f�r beredningar f�r medicinskt eller veten-

skapligt bruk i form av l�sningar som inte inneh�ller mer �n 3 mg/ml

5-(1,1-Dimethylhexyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol

(CP47,497-C6)

5-(1,1-Dimethylheptyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol

(CP47,497-C7)

5-(1,1-Dimethyloctyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol

(CP47,497-C8)

5-(1,1-Dimethylnonyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol

(CP47,497-C9)

Naphthalene-1-yl-(1-pentylindol-3-yl)methanon (JWH-018)
Naphthalene-1-yl-(1-butylindol-3-yl)methanon (JWH-073)
4-metoxinaftalen-1-yl-(1-pentylindol-3-yl)metanon (JWH-081)
4-metylnaftalen-1-yl-(1-pentylindol-3-yl)metanon (JWH-122)
[1-[2-(4-morfolinyl)etyl]-1H-indol-3-yl]-1-naftalenylmetanon (JWH-

200)

2-(2-klorophenyl)-1-(1-pentylindol-3-yl)etanon (JWH-203)
4-etylnaftalen-1-yl-(1-pentylindol-3-yl)metanon (JWH-210)
2-(2-metoxifenyl)-1-(1-pentyl-1H-indol-3-yl)etanon (JWH-250)
(4-klornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon (JWH-398)
(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)

6a,7,10,10a,tetrahydrobenzo[c]chromen-1-ol) (HU-210)

(2-metoxifenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4 orto isomer)
2-(etylamino)-2-(3-metoxifenyl)cyklohexanon (metoxetamin)
1-[(5-fluoropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (AM-2201)
1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-jodofenyl)metanon (AM-694)
N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin

(5-MeO-DALT)

3-[2-[etyl(metyl)amino]etyl]-1H-indol-4-ol (4-HO-MET)
(1-(5-fluoropentyl)-1H-indol-3-yl)(4-metyl-1-naftalen-1-yl)metanon

(MAM-2201)

(1-((1-metylpiperidin-2-yl)metyl)-1H-indol-3-yl)(naftalen-1-yl)-

metanon (AM-1220)

(2-jodofenyl)(1-((1-metylpiperidin-2-yl)metyl)-1H-indol-3-yl)metanon

(AM-2233)

2-(4-jodo-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin

(25I-NBOMe)

2-(4-kloro-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin

(25C-NBOMe)

2-(4-bromo-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin

(25B-NBOMe)

2019:553

background image

5

SFS

2-(2,5-dimetoxi-4-metylfenyl)-N-(2-metoxibensyl)etanamin

(25D-NBOMe)

2-(2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin (25H-NBOMe)
(1-(5-fluoropentyl)-1H-indol-3-yl)(4-etyl-naftalen-1-yl)metanon

(EAM-2201)

2-(4-jodo-2,5-dimetoxifenyl)-N-[(2,3-metylendioxifenyl)metyl]eta-

namin (25I-NBMD)

2-(2,5-dimetoxi-3,4-dimetylfenyl)-N-(2-metoxibensyl)etanamin

(25G-NBOMe)

2-(2,5-dimetoxi-4-nitrofenyl)-N-(2-metoxibensyl)etanamin

(25N-NBOMe)

2-(4-jodo-2,5-dimetoxifenyl)-N-[(3,4-metylendioxifenyl)metyl]eta-

namin (25I-NB34MD)

2-(4-kloro-2,5-dimetoxifenyl)-N-(3,4,5-trimetoxibensyl)etanamin

(C30-NBOMe)

N-[2-(5-metoxi-1H-indol-3-yl)etyl]-N-metylpropan-2-amin

(5-MeO-MIPT)

2-([2-(4-jodo-2,5-dimetoxifenyl)etylamino]metyl)fenol (25I-NBOH)
3-[2-(dipropylamino)etyl]indol (N,N-dipropyltryptamin, DPT)
6-allyl-N,N-dietyl-9,10-didehydroergolin-8-karboxamid (6-allyl-6-nor-

LSD, AL-LAD)

(2,4-dimetylazetidin-1-yl)(6-metyl-9,10-didehydroergolin-8-yl)metanon

(LSZ)

4-allyloxi-3,5-dimetoxifenetylamin (allyleskalin)
4-(2-metyl)allyloxi-3,5-dimetoxifenetylamin (metallyleskalin)
4-etoxi-3,5-dimetoxifenetylamin (eskalin)
2-([2-(4-bromo-2,5-dimetoxifenyl)etylamino]metyl)fenol (25B-NBOH)
2-(4-bromo-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin (25B-NBF)
2-(4-kloro-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin (25C-NBF)
2-(4-jodo-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin (25I-NBF)
2,5-dimetoxi-4-propylfenetylamin (2C-P)
4-acetoxi-N,N-dimetyltryptamin (4-AcO-DMT)
3,5-dimetoxi-4-propoxifenetylamin (proskalin)
1-acetyl-N,N-dietyl-6-metyl-9,10-didehydroergolin-8-karboxamid

(ALD-52)

N,N,6-trietyl-9,10-didehydroergolin-8-karboxamid (ETH-LAD)
2-(8-bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]bensofuran-4-yl)etanamin

(2C-B-FLY)

metyl-2-[1-(5-fluoropentyl)-1H-indol-3-karboxamido]-3,3-dimetyl-

butanoat (5F-MDMB-PICA)

metyl-2-[1-(4-fluorobensyl)-1H-indol-3-karboxamido]-3-metylbutanoat

(MMB-FUBICA, AMB-FUBICA)

3-[1-(piperidin-1-yl)cyklohexyl]fenol (3-hydroxifencyklidin,

3-HO-PCP)

N-etyl-1-(3-metoxifenyl)cyklohexan-1-amin (3-metoxieticyklidin,

3-MeO-PCE)

2-(etylamino)-2-fenylcyklohexan-1-on (deskloro-N-etylnorketamin,

O-PCE)

2-[([2-(4-etyl-2,5-dimetoxifenyl)etyl]amino)metyl]fenol (25E-NBOH)
2-(4-etyl-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin (25E-

NBOMe)

metyl-2-([1-(cyklohexylmetyl)-1H-indazol-3-karbonyl]amino)-3-metyl-

butanoat (AMB-CHMINACA)

2019:553

background image

6

SFS

2-(2-fenylpropan-2-yl)-5-pentyl-2,5-dihydro-1H-pyrido[4,3-b]indol-1-

on (CUMYL-PeGACLONE)

N-[1-(2,3-dihydro-1,4-bensodioxin-6-yl)propan-2-yl]-N-metylhydroxyl-

amin (EFLEA)

N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-[(4-fluorofenyl)metyl]-1H-

indazol-3-karboxamid (ADB-FUBINACA)

[1-(4-fluorobensyl)-1H-indol-3-yl](2,2,3,3-tetrametylcyklo-

propyl)metanon (FUB-144)

[1-(5-fluoropentyl)-1H-indazol-3-yl](naftalen-1-yl)metanon (THJ-2201)
3-(2-[di(propan-2-yl)amino]etyl)-1H-indol-4-ol (4-HO-DIPT)
3-[2-(dimetylamino)etyl]-1H-indol-5-ol (5-HO-DMT)
N,N-dietyl-2-(5-metoxi-1H-indol-3-yl)etanamin (5-MeO-DET)
N-[2-(5-metoxi-1H-indol-3-yl)etyl]-N-metylprop-2-en-1-amin (5-MeO-

MALT)

N-[2-(5-metoxi-1H-indol-3-yl)etyl]propan-2-amin (5-MeO-NIPT)
N-[2-(1H-indol-3-yl)etyl]-N-(propan-2-yl)propan-2-amin (DIPT)
N-[2-(1H-indol-3-yl)etyl]-N-metylpropan-2-amin (MIPT)
N,N-dietyl-6-metyl-1-propanoyl-9,10-didehydroergolin-8-karboxamid

(1P-LSD)

Sm�rtstillande medel

karfentanil
karisoprodol
remifentanil
gamma-hydroxi-butyrat (GHB)
ketamin
tapentadol
tramadol
O-desmetyltramadol (ODT)
3,4-dikloro-N-[[1-(dimetylamino)cyklohexyl]metyl]bensamid

(AH-7921)

1-cyklohexyl-4-(1,2-difenyletyl)piperazin (MT-45)
4-kloro-N-(1-(2-fenyletyl)-piperidin-2-yliden)bensensulfonamid (W-15)
1-[1-(3-metoxifenyl)cyklohexyl]piperidin (3-MeO-PCP)
1-[1-(4-metoxifenyl)cyklohexyl]piperidin (4-MeO-PCP)
2-(etylamino)-2-(2-klorofenyl)cyklohexan-1-on (N-etylnorketamin)
1-(1,2-difenyletyl)piperidin (difenidin)
1-[2-fenyl-1-(2-metoxifenyl)etyl]piperidin (2-MeO-difenidin)
N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]acetamid (acetylfentanyl)
N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]butanamid (butyrfentanyl)
N-[1-(2-fenyletyl)piperidin-4-yl]-N-(2-fluorofenyl)-2-metoxiacetamid

(ocfentanyl)

3,4-dikloro-N-[2-(dimetylamino)cyklohexyl]-N-metylbensamid

(U-47700)

4-kloro-N-(1-[2-(4-nitrofenyl)etyl]piperidin-2-yliden)bensensulfonamid

(W-18)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-2-propenamid (akrylfentanyl)
2-(etylamino)-2-(tiofen-2-yl)cyklohexan-1-on (tiletamin)
N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]furan-2-karboxamid

(furanylfentanyl, Fu-F)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-2-metylpropanamid

(isobutyrfentanyl)

2019:553

background image

7

SFS

metyl-4-[fenyl(metoxiacetyl)amino]-1-[2-(2-tienyl)etyl]piperidin-4-

karboxylat (tiafentanil)

N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-fluorofenyl)-2-metylpropanamid

(4-fluoroisobutyrfentanyl, 4F-iBF)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]cyklopropankarboxamid

(cyklopropylfentanyl)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-2-metoxiacetamid

(metoxiacetylfentanyl)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]tetrahydrofuran-2-karboxamid

(tetrahydrofuranfentanyl, THF-F)

4-bromo-N-[2-(dimetylamino)cyklohexyl]bensamid (bromadolin)
N-[1-(2-fenyletyl)piperidin-4-yl]-N-(2-fluorofenyl)propanamid

(2-fluorofentanyl)

N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-fluorofenyl)butanamid

(4-fluorobutyrfentanyl, 4F-BF)

N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-metoxifenyl)butanamid

(4-metoxibutyrfentanyl, 4-MeO-BF)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]cyklopentankarboxamid

(cyklopentylfentanyl)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]pentanamid (valerylfentanyl)
1-[4-(3-fenylprop-2-en-1-yl)-2-metylpiperazin-1-yl]butan-1-on

(2-metyl-AP-237)

S�mnmedel och lugnande medel

allobarbital
aprobarbital
brallobarbital
brotizolam
butalbarbital
pyrityldion (3,3-dietyl-2,4-dioxotetrahydropyridin)
heptabarbital
hexapropymat
hexobarbital
klometiazol
kloralhydrat
kloralodol
metohexital
metylpentynol
midazolam
tybamat
vinbarbital
zolpidem
zopiclone
fenazepam
etizolam (4-(o-klorofenyl)-2-etyl-9-metyl-6H-tieno[3,2-f]-s-tria-

zolo[4,3-a][1,4]diazepin)

8-bromo-1-metyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benso-

diazepin (pyrazolam)

7-bromo-5-(2-fluorofenyl)-1,3-dihydro-2H-1,4-bensodiazepin-2-on

(flubromazepam)

7-kloro-5-(2-klorofenyl)-1,3-dihydro-1-metyl-2H-1,4-bensodiazepin-

2-on (diklazepam)

2019:553

background image

8

SFS

(8-bromo-6-(2-fluorofenyl)-1-metyl-4H-[1,2,4]triazolo[4,3-a][1,4] ben-

sodiazepin (flubromazolam)

5-(2-klorofenyl)-3-metyl-7-nitro-1,3-dihydro-2H-[1,4]-bensodiazepin-

2-on (meklonazepam)

6-(2-klorofenyl)-1-metyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]bensodia-

zepin (klonazolam)

2-etyl-4-fenyl-9-metyl-6H-tieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin

(deskloretizolam)

2-etyl-4-(2-klorofenyl)-6H-tieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]dia-

zepin (metizolam)

1-(6-fenyl-8-kloro-4H-[1,2,4]triazolo[4,3-a][1,4]bensodiazepin-1-yl)-

N,N-dimetylmetanamin (adinazolam)

1-(cyklopropylmetyl)-5-(2-klorofenyl)-7-nitro-1,3-dihydro-2H-[1,4]-

bensodiazepin-2-on (kloniprazepam)

8-kloro-6-(2-klorofenyl)-4H-pyrido[2,3-f][1,2,4]triazolo[4,3-a][1,4]dia-

zepin (zapizolam)

5-(2-fluorofenyl)-3-hydroxi-7-nitro-1,3-dihydro-2H-1,4-bensodiazepin-

2-on (nifoxipam, 3-hydroxidesmetylflunitrazepam)

7-bromo-3-hydroxi-5-(2-klorofenyl)-1,3-dihydro-2H-1,4-bensodiazepin-

2-on (3-hydroxifenazepam)

6-(2-fluorofenyl)-1-metyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]bensodi-

azepin (flunitrazolam)

5-(2-fluorofenyl)-1,3-dihydro-7-nitro-2H-1,4-bensodiazepin-2-on

(N-desmetylflunitrazepam)

8-bromo-6-fenyl-1-metyl-4H-[1,2,4]triazolo[4,3-a][1,4]bensodiazepin

(bromazolam)

5-(2-fluorofenyl)-7-kloro-1,3-dihydro-2H-1,4-bensodiazepin-2-on

(norfludiazepam)

6-(2-fluorofenyl)-8-kloro-1-metyl-4H-[1,2,4]triazolo[4,3-a][1,4]benso-

diazepin (flualprazolam)

6-fenyl-1-metyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]bensodiazepin

(nitrazolam)

(3S)-3-(aminometyl)-5-metylhexansyra (pregabalin)
5-(2-klorofenyl)-1-metyl-7-nitro-1,3-dihydro-2H-1,4-bensodiazepin-

2-on (metylklonazepam)

5-fenyl-1,3,6,7,8,9-hexahydro-2H-[1]bensotieno[2,3-e][1,4]diazepin-2-

on (bentazepam)


Som narkotika enligt narkotikastrafflagen ska �ven anses de ovanjordiska

delarna av v�xten kat (Catha edulis) samt svamparna Psilocybe semilanceata
(toppsl�tskivling) och Psilocybe cubensis. Detsamma ska g�lla andra
svampar som inneh�ller �mnena psilocybin eller psilocin, om svamparna �r
framodlade eller om de har torkats eller p� annat s�tt beretts.

Vidare ska vid till�mpning av lagen med cannabis f�rst�s de ovanjordiska

delarna av varje v�xt av sl�ktet Cannabis (med undantag av fr�n), fr�n vilka
hartset inte blivit extraherat och oavsett under vilka ben�mningar de f�re-
kommer. Med cannabis ska dock inte f�rst�s hampa som

1. �r av en sort som kan ber�ttiga till st�d enligt r�dets f�rordning (EG)

nr 73/2009 av den 19 januari 2009 om uppr�ttande av gemensamma best�m-
melser f�r system f�r direktst�d f�r jordbrukare inom den gemensamma
jordbrukspolitiken och om uppr�ttande av vissa st�dsystem f�r jordbrukare,
om �ndring av f�rordningarna (EG) nr 1290/2005, (EG) nr 247/2006 och
(EG) nr 378/2007 samt om upph�vande av f�rordning (EG) nr 1782/2003,

2019:553

background image

9

SFS

Europaparlamentets och r�dets f�rordning (EU) nr 1307/2013 av den 17 de-
cember 2013 om regler f�r direktst�d f�r jordbrukare inom de st�dordningar
som ing�r i den gemensamma jordbrukspolitiken och om upph�vande av
r�dets f�rordning (EG) nr 637/2008 och r�dets f�rordning (EG) 73/2009,
och Europaparlamentets och r�dets f�rordning (EU) nr 1308/2013 av den
17 december 2013 om uppr�ttande av en samlad marknadsordning f�r jord-
bruksprodukter och om upph�vande av r�dets f�rordningar (EEG)
nr 922/72, (EEG) nr 234/79, (EG) nr 1037/2001 och (EG) nr 1234/2007, och

2. odlas efter det att ans�kan om direktst�d f�r s�dan odling enligt r�dets

f�rordning (EG) nr 1307/2013 eller r�dets f�rordning (EG) nr 73/2009 getts
in till beh�rig myndighet.

2019:553

;